gvtcx

STRATA Clinical Trial

University of Bristol Published 19 Dec 2019 Contracts Finder

key details

Value£70,000
Statusactive
Category (CPV) 33000000 +1 more
RegionSouth West
Deadline20 Jan 2020
Contract start31 Jan 2020
Contract end31 Jan 2021
Procedureopen
SME suitableYes
OCIDocds-b5fd17-7539a0d2-5d28-4e03-8d14-f9c01e109ec2

description

STRATA Clinical Trial - Seteraline drug and placebo for a Clinical Trial; Autism in adults in the UK and Australia. Anxiety is common in adults with a diagnosis of autism and can be more disabling than the core features of autism. Medications for anxiety are often prescribed for adults with autism but their effectiveness or side effects in this population are not well known.

Aims: i) to determine the effectiveness of the Selective Serotonin Reuptake Inhibitor (SSRI) sertraline in reducing symptoms of anxiety and improving quality of life in adults with a diagnosis of autism compared with placebo and quantify its adverse effects; ii) to determine its cost effectiveness; iii) to explore patients' views and experiences of taking study medication and identify reasons for completing/not completing the study.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
19 Dec 2019 Tender (tender) · 48888fae-5fd6-4c98-b313-3d333e2aa14b-333402

more from University of Bristol

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.